Bharat Biotech: Covaxin phase-3 results show interim efficacy of 81%
Bharat Biotech on Wednesday announced the phase 3 results of its coronavirus vaccine ‘Covaxin’ claiming the shots have demonstrated an interim clinical efficacy of nearly 81%.
Written By: Zee Business Video Team